Search Results 291-300 of 11734 for Drug-resistant TB

  1. Medical Research & Education - Mayo Clinic News Network

    ... drug-resistant epilepsy. Alison Satake. April 7, 2025. Hidden mutation leads to ... drug-resistant. Featured News. (VIDEO) When seizures don't stop: The ...

  2. Viral Therapy In Treating Patients With Recurrent Or Metastatic Squamous Cell Carcinoma Of The Head And Neck Cancer Or Metastatic Breast Cancer - Mayo Clinic

    History of tuberculosis or history of tuberculin purified protein derivative (PPD) positivity; Any of the following prior therapies: * Chemotherapy ≤ 3 ...

  3. https://www.mayoclinic.org/chinese_condition_consolidated_concepts.xml

    ... treatment/drc-20350080</loc><lastmod>2024-08-12T21:02:33-05:00</lastmod><xhtml:link rel="alternate" hreflang="ar" href="https://www.mayoclinic.org/ar ...

  4. Infectious Diseases - Clinical trials

    A Study to Evaluate the QuantiFERON-TB Gold-Plus Test for Blood Detection of Tuberculosis without Symptoms. Rochester, Minn. The purpose of this study is to ...

  5. Medical Research & Education - Mayo Clinic News Network

    ... drug-resistant. Featured News. New study in Brain Communications finds personalized deep brain stimulation shows promise for drug-resistant epilepsy. Alison ...

  6. Tocilizumab (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

    Drug Interactions. Although certain medicines should not be used ... Tuberculosis, history of—Use with caution. May cause infections to come back ...

  7. A Study Of Pembrolizumab (MK-3475) Versus Placebo In Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy In The Treatment Of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer - Mayo Clinic

    A Study Of Pembrolizumab (MK-3475) Versus Placebo In Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy In The Treatment Of Early-Stage ...

  8. A Study of Topical Antibiotics in Chronic Rhinosinusitis - Mayo Clinic

    The purpose of this study is to describe the results of antibiotic resistant organisms after the use of topical antibiotics in the treatment of chronic ...

  9. Detection of Microorganisms and Antibiotic Resistance Genes Using the Curetis UnyveroTM LRT55 Application - Mayo Clinic

    About this study. The Curetis Unyvero LRT55 Application is intended to detect and to identify genes of 21 microorganisms and 19 genes associated with ...

  10. Mirikizumab-mrkz (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

    ... tuberculosis test or been exposed to tuberculosis. ... Bleeding, blistering, burning, coldness, discoloration of the skin, feeling of ... Drug information provided ...